TREACE MEDICAL CONCEPTS, INC. Quarterly Debt-to-equity in % from Q3 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Treace Medical Concepts, Inc. quarterly Debt-to-equity history and growth rate from Q3 2021 to Q3 2024.
  • Treace Medical Concepts, Inc. Debt-to-equity for the quarter ending September 30, 2024 was 94 %, a 21.2% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 94 +16.4 +21.2% Sep 30, 2024
Q2 2024 86.9 -2.37 -2.66% Jun 30, 2024
Q1 2024 78.3 -27.1 -25.7% Mar 31, 2024
Q4 2023 69.9 -50.8 -42.1% Dec 31, 2023
Q3 2023 77.5 -14.5 -15.7% Sep 30, 2023
Q2 2023 89.2 +22 +32.7% Jun 30, 2023
Q1 2023 105 +56.3 +114% Mar 31, 2023
Q4 2022 121 +64.2 +114% Dec 31, 2022
Q3 2022 92 +12.8 +16.2% Sep 30, 2022
Q2 2022 67.3 Jun 30, 2022
Q1 2022 49.2 Mar 31, 2022
Q4 2021 56.5 Dec 31, 2021
Q3 2021 79.2 Sep 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.